Machine learning models based on log odds of positive lymph nodes for predicting survival in T1N+ gastric cancer
Abstract
Background Although early gastric cancer (EGC) is generally limited to the mucosal and submucosal layers, lymph node metastasis can still occur, which may worsen the prognosis, particularly when the number of examined lymph nodes (ELNs) is inadequate. This study introduces log odds of positive lymph nodes (LODDS) as a prognostic factor and integrates it with machine learning to improve survival predictions in T 1 N + gastric cancer (GC). Methods This retrospective study used data from the Surveillance, Epidemiology, and End Results (SEER) Program and an independent validation cohort from the Chinese People’s Liberation Army General Hospital First Medical Center. Predictive factors were selected using LASSO regression and multivariate Cox regression. Cox proportional-hazards (CoxPH), random survival forest (RSF), and XGBoost models were developed to predict overall survival (OS). Model interpretability and feature importance were evaluated using the SHapley Additive exPlanations (SHAP) method. Results A total of 419 T 1 N + GC patients from the SEER database and 193 from our institution were included in the study. LODDS staging was identified as an independent prognostic factor, demonstrating superior discriminatory power compared to N staging (C-index 0.65 vs. 0.57). Based on the Brier score, area under the ROC curve (AUC), and C-index, the RSF model outperformed both the Cox model and XGBoost model. The RSF model achieved a C-index of 0.79 in the training cohort and 0.80 in the validation cohort, indicating favorable discrimination and calibration, with Brier scores below 0.25. Conclusions Integrating LODDS staging into the RSF model, alongside other clinical features, provides a highly accurate tool for survival prediction in T 1 N + GC patients.
Fields of Study & Subjects
Gastric Cancer Management and Outcomes
Cholangiocarcinoma and Gallbladder Cancer Studies
Esophageal Cancer Research and Treatment
Publication details
- Journal / source
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Volume
- 15
- Pages
- 1642302–1642302
- Publication date
- 9 January 2026
- Language
- EN